Search research articles
Contact Us
Filters
Showing results (1-10 of 328) with videos related to
Page
of 33
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 5, 2021
Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer
Lynette M Sholl
Histopathology
|
December 18, 2019
Programmed death ligand 1 immunohistochemistry: can we agree on this?
Lynette M Sholl
Seminars in Respiratory and Critical Care Medicine
|
May 26, 2020
Molecular Diagnostics in Non-Small Cell Lung Carcinoma
Lynette M Sholl
Archives of Pathology & Laboratory Medicine
|
September 26, 2014
Biomarkers in lung adenocarcinoma: a decade of progress
Lynette M Sholl
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 24, 2017
Next-Generation Sequencing from Liquid Biopsies in Lung Cancer Patients: Advances in Comprehensive Biomarker Testing
Lynette M Sholl
Current Opinion in Pulmonary Medicine
|
May 10, 2014
Large-cell carcinoma of the lung: a diagnostic category redefined by immunohistochemistry and genomics
Lynette M Sholl
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 25, 2018
Recognizing the Challenges of Oncogene Fusion Detection: A Critical Step toward Optimal Selection of Lung Cancer Patients for Targeted Therapies
Lynette M Sholl
Seminars in Diagnostic Pathology
|
March 11, 2015
Protein correlates of molecular alterations in lung adenocarcinoma: Immunohistochemistry as a surrogate for molecular analysis
Lynette M Sholl
Clinical Chemistry
|
March 31, 2015
Commentary
Lynette M Sholl
Surgical Pathology Clinics
|
August 16, 2016
The Molecular Pathology of Lung Cancer
Lynette M Sholl
Page
of 33
Search research articles
Search
Showing results (1-10 of 328) with videos related to
Sort By:
Page
of 33
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 5, 2021
Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer
Lynette M Sholl
Histopathology
|
December 18, 2019
Programmed death ligand 1 immunohistochemistry: can we agree on this?
Lynette M Sholl
Seminars in Respiratory and Critical Care Medicine
|
May 26, 2020
Molecular Diagnostics in Non-Small Cell Lung Carcinoma
Lynette M Sholl
Archives of Pathology & Laboratory Medicine
|
September 26, 2014
Biomarkers in lung adenocarcinoma: a decade of progress
Lynette M Sholl
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 24, 2017
Next-Generation Sequencing from Liquid Biopsies in Lung Cancer Patients: Advances in Comprehensive Biomarker Testing
Lynette M Sholl
Current Opinion in Pulmonary Medicine
|
May 10, 2014
Large-cell carcinoma of the lung: a diagnostic category redefined by immunohistochemistry and genomics
Lynette M Sholl
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 25, 2018
Recognizing the Challenges of Oncogene Fusion Detection: A Critical Step toward Optimal Selection of Lung Cancer Patients for Targeted Therapies
Lynette M Sholl
Seminars in Diagnostic Pathology
|
March 11, 2015
Protein correlates of molecular alterations in lung adenocarcinoma: Immunohistochemistry as a surrogate for molecular analysis
Lynette M Sholl
Clinical Chemistry
|
March 31, 2015
Commentary
Lynette M Sholl
Surgical Pathology Clinics
|
August 16, 2016
The Molecular Pathology of Lung Cancer
Lynette M Sholl
Page
of 33